Literature DB >> 7028084

A double-blind comparison of topical therapy of chlamydial ocular infection (TRIC infection) with rifampicin or chlortetracycline.

S Darougar, N Viswalingam, H El-Sheikh, P A Hunter, P Yearsley.   

Abstract

A double-blind stratified trial was carried out on 85 patients to assess the efficacy of topical therapy with 1% chlortetracycline eye ointment in comparison with 1% rifampicin eye ointment in the treatment of chlamydial ocular infection of sexually transmitted origin (paratrachoma). Patients included were selected on the basis of positive culture for Chlamydia trachomatis. A 6-week course of treatment with chlortetracycline or rifampicin 3 times daily gave a clinical cure rate of 80% and 75% and a microbiological cure rate of 93% and 86% respectively. In patients who were not cured the intensity of inflammatory responses was considerably reduced.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7028084      PMCID: PMC1039580          DOI: 10.1136/bjo.65.8.549

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  4 in total

1.  Blinding and non-blinding trachoma: assessment of intensity of upper tarsal inflammatory disease and disabling lesions.

Authors:  C R Dawson; B R Jones; S Darougar
Journal:  Bull World Health Organ       Date:  1975       Impact factor: 9.408

2.  Conjunctival swabbing for the isolation of TRIC agent (Chlamydia).

Authors:  S Darougar; B R Jones
Journal:  Br J Ophthalmol       Date:  1971-09       Impact factor: 4.638

3.  Topical therapy of hyperendemic trachoma with rifampicin, oxytetracycline, or spiramycin eye ointments.

Authors:  S Darougar; B R Jones; N Viswalingam; J Allami; D Minassian; M A Farahmandian; A Houshmand
Journal:  Br J Ophthalmol       Date:  1980-01       Impact factor: 4.638

4.  Treatment of TRIC infection of the eye with rifampicin or chloramphenicol.

Authors:  S Darougar; M Viswalingam; J D Treharne; J R Kinnison; B R Jones
Journal:  Br J Ophthalmol       Date:  1977-04       Impact factor: 4.638

  4 in total
  7 in total

1.  Oral doxycycline in the treatment of adult chlamydial ophthalmia.

Authors:  N D Viswalingam; S Darougar; P Yearsley
Journal:  Br J Ophthalmol       Date:  1986-04       Impact factor: 4.638

2.  Development of a Broad-Spectrum Antimicrobial Combination for the Treatment of Staphylococcus aureus and Pseudomonas aeruginosa Corneal Infections.

Authors:  Michaelle Chojnacki; Alesa Philbrick; Benjamin Wucher; Jordan N Reed; Andrew Tomaras; Paul M Dunman; Rachel A F Wozniak
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

3.  Rifampicin in non-tuberculous infections.

Authors:  A J Davies; D A Lewis
Journal:  Br Med J (Clin Res Ed)       Date:  1984-07-07

4.  Rifampin Enhances the Activity of Amphotericin B against Fusarium solani Species Complex and Aspergillus flavus Species Complex Isolates from Keratitis Patients.

Authors:  Yi He; Lutan Zhou; Chuanwen Gao; Lei Han; Yan Xu
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

Review 5.  Is ophthalmology evidence based? A clinical audit of the emergency unit of a regional eye hospital.

Authors:  T Y Y Lai; V W Y Wong; G M Leung
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

Review 6.  Use of rifampin in nonstaphylococcal, nonmycobacterial disease.

Authors:  A B Morris; R B Brown; M Sands
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

7.  Antibiotics for trachoma.

Authors:  Jennifer R Evans; Anthony W Solomon; Rahul Kumar; Ángela Perez; Balendra P Singh; Rajat Mohan Srivastava; Emma Harding-Esch
Journal:  Cochrane Database Syst Rev       Date:  2019-09-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.